Brief: Ultimovacs Q4 Total Loss At NOK 55.9 Mln
Feb 14 (Reuters) - Ultimovacs ASA ULTI.OL :
* TOTAL OPERATING EXPENSES AMOUNTED TO MNOK 59.6 IN Q4 2023
AND
MNOK 215.7 FY 2023
* TOTAL LOSS WAS MNOK 55.9 FOR QUARTER AND MNOK 189.2 IN
FY2023
* NET NEGATIVE CASH FLOW FROM OPERATIONS WAS MNOK 42.4 IN Q4
2023
Source text for Eikon: ID:nGNE5yXx75
Further company coverage: ULTI.OL
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Zelluna ASA
See all newsNorway's Zelluna ASA reports Q2 loss
Brief: Zelluna Reports Q2 Total Loss Of NOK 19.7 Million
Brief: Zelluna Says IDMC Recommends Recruitment Of Next Two Patients At First Dose Level
Brief: Zelluna Says First Patient Dosed With Zi-Ma4-1 In Zima-101 Phase 1 Trial
Brief: Zelluna Wins NOK 16 Mln Research Council Of Norway Grant